(Co)-first Authored Publications

  1. Petroni, G., Galassi, C. Gouin 3rd, K.H. et al. IL17A-secreting γδ T cells promote resistance to CDK4/6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages. Nat Cancer, 2025. 6(10): p. 1656-1675.
  2. Galassi, C., Petroni, G., Knott, S.R.V. and L. Galluzzi. An immunological mechanism of resistance to CDK4/6 inhibitors in HR+ breast cancer. Oncoimmunology, 2025. 14(1): p. 2520269.
  3. Galassi, C., Manic, G., Esteller, M. et al. Epigenetic regulation of cancer stemness. Signal Transduct Target Ther, 2025. 10(243): p. 1-19.
  4. Galassi, C., Esteller, M., Vitale, I. and L. Galluzzi. Epigenetic control of immunoevasion in cancer stem cells. Trends Cancer. 2024. 10(11): p. 1052-1071.
  5. Galassi, C., Chan, T.A., Vitale, I. and L. Galluzzi. The hallmarks of cancer immune evasion. Cancer Cell. 2024. 42(11): p.1825-1863.
  6. Galassi, C., Klapp, V., Yamazaki, T. et al. Molecular determinants of immunogenic cell death elicited by radiation therapy. Immunol Rev, 2024. 321(1): p. 20-32.
  7. Galassi, C., Klapp, V., Formenti, S.C., et al. Immunologically relevant effects of radiation therapy on the tumor microenvironment. Essays Biochem, 2023. 67(6): p. 979-989.
  8. Galassi C. and L. Galluzzi. Cancer stem cell immunoediting by IFNγ. Cell Death Dis, 2023. 14(8): p. 143.
  9. Galassi, C. and L. Galluzzi. Epigenetic escape of immunosurveillance by malignant cell precursors. EMBO J, 2023. 42(10):e114050.
  10. Galassi, C., Ruan, Y., Sato, A. et al. RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. Methods Cell Biol, 2022. 172: p. 145-161.
  11. Galassi, C., Vitale, I. and L. Galluzzi. Using epigenetic modifiers to target cancer stem cell immunoevasion. Cancer Cell, 2021. 39(12): p. 1573-1575.  

(Co)-senior Authored Publications 

  1. Campia, G., Beltrán-Visiedo, M., Soler-Agesta, R. et al. Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line. Methods Cell Biol, 2024. 189: p. 153-168.
  2. Galassi, C., Klapp, V., Yamazaki, T. et al. Molecular determinants of immunogenic cell death elicited by radiation therapy. Immunol Rev, 2024. 321(1): p. 20-32.

Abstracts Selected for Poster Presentation (First/co-first and last/co-last only) 

  1. Galassi, C., Petroni, G., Iribarren, C. and L. Galluzzi. An immunological mechanism of resistance to CDK4/6 inhibitors in breast cancer. Keystone Symposium Cancer Immunotherapy: Beyond Immune Checkpoint Blockade and Overcoming Resistance (March 2024). 
  2. Galassi C., Petroni, G., Iribarren, C. and L. Galluzzi. An immunological mechanism of resistance to CDK4/6 inhibitors in breast cancer. Keystone Symposium Innate Immunity Across the Molecular, Cellular, Tissue and Therapeutic (April 2024)

Abstracts selected for Oral Presentation (First/co-first and last/co-last only)

  1. Galassi, C., Petroni, G. and L. Galluzzi. An immunological mechanism of resistance to CDK4/6 inhibitors in breast cancer. Paris Immuno-Oncology (PIO) Conference (October 2024).
  2. Galassi C. γδ T cells underlie resistance to CDK4/6 inhibitors in HR+ breast cancer. CIMT Summer School (September 2022).

Fellowships

  1. American Italian Cancer Foundation (AICF) 2023/2024 Post-doc Research Fellowship 
  2. American Italian Cancer Foundation (AICF) 2022/2023 Post-doc Research Fellowship

Other Achievements

  1. Arthur and Sandra Irving Cancer Immunology Symposium (2024)
  2. SITC Women in Cancer Immunotherapy Network (WIN) Member (2023)
  3. Radiation Oncology-Biology Integration Network (ROBIN) Young Scientists Exchange Program (YSEP) Award (2023)
  4. CIMT Summer School Trainee (2022)

My Bibliography Link

https://www.ncbi.nlm.nih.gov/myncbi/1HUEiwwRI88Itd/bibliography/public/